Diabetes Centers

Enhancing and extending the effectiveness of diabetes research by encouraging collaboration among investigators from relevant disciplines.

NIDDK Program Staff

  • Corinne M. Silva, Ph.D. Signaling pathways, nuclear receptors and nutrient sensing in metabolic tissues; role of intrauterine environment in offspring metabolic disease; Diabetes Research Centers
  • Pamela L. Thornton, Ph.D. Health Equity and Translational Research; Centers for Diabetes Translation Research (P30) Program

On this page:

Funding for Diabetes Centers

NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. The program supports and enhances interdisciplinary research in diabetes but does not directly fund major research projects; rather, it provides core resources to enhance the efficiency, productivity, and interdisciplinary cooperation of Center investigators conducting research in diabetes and related areas of endocrinology and metabolism.

NIDDK funds Diabetes Centers via P30. Please see the Diabetes Research Centers (DRC) application resources or the Centers for Diabetes Translation Research (CDTR) application resources for tables and additional documentation required in all Diabetes Centers applications.

Centers are funded on the following review schedule:

  • CDTR: announcements are published once every 5 years
  • DRC: are published three times every 5 years

Resources and Services Available from Diabetes Centers

NIDDK Diabetes Centers generate investigative resources that are available to the broader research community. Centers also provide short-term enrichment activities, as well as pilot and feasibility programs that fund small research grants designed to generate preliminary data for larger grant applications.

For more information about each Diabetes Center’s aims, shared resources, pilot and feasibility programs, enrichment programs, and activities, please visit their websites:

Diabetes Research Centers (DRCs)

The DRCs promote new discoveries and enhance scientific progress through support of cutting-edge basic and clinical research related to the etiology and complications of diabetes, with the goal of rapidly translating research findings into novel strategies for the prevention, treatment and cure of diabetes and related conditions. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes and related endocrinology and metabolism research by providing shared access to specialized technical resources and expertise and by creating an environment that supports important and innovative research. DRCs are expected to raise awareness and interest in fundamental and clinical diabetes research at their institutions, as well as locally, regionally, and nationally.

Albert Einstein-Mount Sinai Diabetes Center
  • Research Aims: Investigations primarily target the minority and other served under populations prevalent among the residents of the Bronx and Manhattan, adjacent Westchester county, and other boroughs comprising New York City. The primary research efforts encompass both type 1 (T1DM) and type 2 (T2DM) diabetes and related metabolic defects.
  • Activities & Services
    • Cores
      • Animal Physiology Core
      • Immuno-Technology
      • The Human Islet & Adenovirus
      • Stable Isotope & Metabolomics
      • Translational Research
    • Pilot & Feasibility Program
      •  Supports
        • New investigators with interests in diabetes or related metabolic and endocrine disorders, including junior investigators shifting from mentor-based research to an independent career. Meritorious applications from new investigators receive priority for funding.
        • Established faculty in other areas who wish to apply their expertise to diabetes research.
        • Diabetes Center members who wish to explore a new area of research that constitutes a substantive departure from their on-going work.
Boston Area
  • Research Aims: A consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes, and their associated microvascular and atherosclerotic complications.
  • Activities & Services
Columbia University
  • Research Aims: The DRC provides a central support structure to foster collaboration among investigators working in the areas of diabetes, immunology, transplantation, obesity and arteriosclerosis/lipid research and supports their activities by providing shared core resources, funding for pilot/feasibility studies and a common intellectual environment.
  • Activities & Services
    • Cores
      • Translational Biomarker Analytical Core
      • Cytometry and Cell Sorting Core
      • Advanced Tissue Pathology and Imaging Core
      • Mouse Metabolic Function and Phenotyping Core
    • Pilot & Feasibility Program
Indiana University
  • Research Aims: The mission of the new, integrated Indiana Diabetes Research Center (IDRC) is to foster knowledge, support training, and promote basic and translational research in diabetes and related metabolic disorders, and their complications.
  • Activities & Services

Joslin Diabetes Center - Harvard Medical School

  • Research Aims: The mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
  •  Activities & Services
    • Cores
      • Animal Physiology Core
      • Flow Cytometry Core
      • Molecular Phenotyping and Genotyping Core
      • Clinical Translational Core
      • Genome Editing Core
    • Pilot & Feasibility Program
      • Enhance research into the pathogenesis, treatments and potential cures for all types of diabetes and their complications more generally.

North Carolina Diabetes Research Center

  • Research Aims: The North Carolina Diabetes Research Center supports an interactive diabetes research community across four premiere research institutions in North Carolina: Duke University (Duke) The University of North Carolina at Chapel Hill (UNC), Wake Forest School of Medicine (WF), and North Carolina A&T (NC A&T). 
  • Activities & Services 
    • Cores
      • Genomics and Proteomics
      • Metabolomics
    • Pilot & Feasibility Program
      • The North Carolina Diabetes Research Center Pilot & Feasibility Program will encourage use of regional Cores, bring to the field new investigators and young scientists, and draw those not previously working in the field. 
Stanford University
  • Research Aims: The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
  • Activities & Services
    • Cores
      • Diabetes Immune Monitoring Core
      • Clinical and Translational Core
      • Islet Research Core
      • Diabetes Genomics and Analysis Core
    • Pilot & Feasibility Program
University of Alabama at Birmingham
  • Research Aims: The center focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.  The DRC supports the areas of animal physiology, human biology and intervention and translational research.
  • Activities & Services
    • Cores
      • Animal Physiology Core (APC)
      • Human Physiology Core (HPC)
      • Interventions and Translation Core (ITC)
    • Pilot & Feasibility Program
      • The P&F program will foster new research programs in diabetes and support a broad base of basic, clinical, translational, and prevention and control projects.
  • Research Aims: The center fosters research in the prevention and treatment of diabetes and endocrine diseases and their complications and ultimately to improves the lives of endocrine patients.
  • Activities & Services
    • Cores
      • Transgenic and Knockout Mouse
      • Metabolic and Molecular Physiology
      • Transcriptional Genomics
      • Epigenetic and Genomics
      • Human Genetics
    • Pilot & Feasibility Program
      • The DRC P&F mechanism will fund innovative new projects that will explore the feasibility of novel testable concepts and enhance the endocrine/diabetes research scope within the institutions.

UCSF

  • Research Aims: The research components of the UCSF DRC include the following four areas:
    • Islet Biology Program
    • Obesity & Metabolism Program
    • Autoimmunity & Inflammation Program
    • Translation Program
  • Activities & Services
University of Chicago
  • Research Aims: The University of Chicago Diabetes Research and Training Center promotes multidisciplinary research in diabetes.
  • Activities & Services
    • Cores
      • Cell Biology Core
      • Genetics and Genomics Core
      • Physiology Core
    • Pilot & Feasibility Program
      • Supports new investigators in diabetes research as well as established investigators in other fields to conduct novel research related to diabetes.
University of Colorado
  • Research Aims:
    • The University of Colorado Denver (UC Denver) is world renowned for basic, translational, and clinical diabetes research and treatment of both Type 1 and Type 2 diabetes (T1D and T2D), and their related complications.
  • Activities & Services
    • Cores
      • Clinical Resource
      • Tissue Procurement and Processing
      • Cell and Tissue Analysis
      • Disease Modeling
    • Pilot & Feasibility Program
      • The UC Denver Pilot & Feasibility Program will recruit young faculty into diabetes and diabetes-related research and encourage established investigators from other fields to enter the diabetes field.

University of Michigan

  • Research Aims: The goal of the MDRC is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
  • Activities & Services
    • Cores
      • Animal Studies Core
      • Clinical Core
      • Molecular Genetics Core
      • Microscopy, Imaging, and Cellular Physiology Core
    • Pilot & Feasibility Program
      • Proposals must focus on type 2 translational research in diabetes: the translation of research advances into widespread clinical or community practice. The research may focus on the identification of barriers to widespread adoption of new science and the testing of interventions to overcome those barriers. 

University of Pennsylvania

  • Research Aims: Supports research in diabetes and endocrinology via Scientific Cores, a Pilot and Feasibility Grant Program, and a series of seminars, retreats and other activities that facilitate communication and collaboration of DRC investigators while keeping them abreast of the latest discoveries in diabetes and endocrinology.
  • Activities & Services
    • Cores
      • Functional Genomics Core
      • Metabolomics Core
      • Islet Cell Biology Core
      • Mouse Phenotyping, Physiology and Metabolism Core
      • Radioimmunoassy/Biomarker Core
      • Transgenic and Chimeric Mouse Core
      • Viral Vector Core
    • Pilot & Feasibility Program
      • The P&F program is particularly directed at new investigators and established investigators new to diabetes research. Established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical and translational investigators.

University of Washington

  • Research Aims: Facilitating and enhancing diabetes research to find a cure to diabetes.
  • Activities & Services
    • Cores
      • Cell Function Analysis Core
      • Cellular and Molecular Imaging Core
      • Quantitative and Functional Proteomics Core
      • Vector and Transgenic Mouse Core
    • Pilot & Feasibility Program
      • Intended to develop new research in the area of diabetes and its complications at the University of Washington.

Washington University

  • Research Aims: Our long-term goal is the development of new preventive strategies and therapies aimed at improving the lives of Americans with diabetes and those at risk for diabetes and related metabolic disorders.
  • Activities & Services
    • Cores
      • Diabetes Models Phenotyping Core
      • Transgenic & ES Cell Core
      • Translational Diagnostics Core
      • Cell and Tissue Imaging Core
      • Metabolic Tissue Function Core
      • Metabolomics Core
    • Pilot & Feasibility Program

Yale University

  • Research Aims: The scope of the research activities of the membership is very broad, ranging from basic molecular biology to whole body clinical physiology in patients with diabetes.
  • Activities & Services
    • Cores
      • Cell Biology Core
      • Clinical Metabolism Core
      • Diabetes Translational Core
      • Physiology Core
      • Molecular Genetics Core
    • Pilot & Feasibility Program
      • Priority will be given to new collaborative investigations.

Centers for Diabetes Translation Research (CDTRs)

The CDTR  mission is to improve translation of research related to diabetes prevention, treatment, and health equity by supporting research across the T2-T4 translational spectrum (e.g., moving from efficacy to testing effectiveness in real world practice and communities and dissemination and implementation science).  CDTRs are intended to enhance the efficiency, productivity, and multidisciplinary and multisectoral nature of diabetes translation research through shared access to specialized technical expertise and resources.  CDTRs' expertise includes intervention adaptation and refinement, development of measures, techniques, processes, methods, and practices related to diabetes translation research. These innovative Centers along with their diverse partnership models provide the infrastructure needed to advance translational research in health disparities and health equity by providing core services and consultation at their local institutions, as well as resources regionally and nationally.

Einstein College of Medicine
  • Research Aims: The aim of the New York Regional Center for Diabetes Translation Research is to increase collaboration and enhance communication among investigators from multiple institutions and diverse disciplines. There is a focus on the following unifying themes – health equity and addressing differences in population health status that can be traced to unequal economic and social conditions; and using a biopsychosocial approach to integrate diabetes and obesity translational research through consideration of biological, psychological, and social determinants of health and disease.
  • Activities & Services
    • Cores
      • Behavioral Science and Technology Core (BSTC)
      • Life Course Methodology Core 
      • Population Health and Health Systems (PHHS) Core 
      • National Core: Latino Network for Diabetes Translational Research 
    • Enrichment Program
    • Pilot & Feasibility Program

Emory University

  • Research Aims: The Georgia Center for Diabetes Translation Research (GCDTR) focuses on advancing the science regarding the reach, effectiveness, adoption, and sustainability of technological, behavioral, pharmacological diabetes prevention and management advances. To do this, GCDTR leverages design and evaluation expertise; careful application of socioecological models, behavioral sciences, and community-engaged participatory research that can improve engagement with clinical, policy, and community stakeholders; and established and emerging technologies to advance translation research for health equity.
  • Activities & Services
    • Cores
      • Design and Evaluation for Equity Core
      • Socioecological and Behavioral Science for Equity Core
      • Regional Core: Technologies Advancing Translation and Equity Core
    • Enrichment Program
    • Pilot & Feasibility Program

Kaiser Foundation Research Institute 

  • Research Aims: The Diabetes Research for Equity through Advanced Multilevel Science Center for Diabetes Translational Research (DREAMS-CDTR) aims to advance health equity science through the development and translation of: 1) innovations and structural changes to healthcare delivery systems that substantively reduce health inequalities, and 2) innovative, scalable interventions to alter the socioenvironmental drivers of the Type 2 Diabetes epidemic and associated disparities. Focusing on the northern California and Central Valley regions of California, the DREAMS-CDTR will provide research resources for investigators to conduct clinical research and interventions designed to inform practice and policy change at the health system, community and policy levels. The DREAMS-CDTR (formerly Health Delivery Systems) brings together translational science core faculty who have expertise in diverse, multi-level areas including: food insecurity, medication adherence, health communication, health IT, social policy, and cost effectiveness analysis. DREAMS-CDTR involves five regional academic sites with a range of public and non-profit health systems that serve large and diverse populations: Kaiser Permanente Northern California’s Division of Research, Stanford University and the University of California at San Francisco, Merced and Davis.
  • Activities & Services
    • Cores
      • Health Equity and Action Translational (HEAT) Core
      • Methods and Data Integration (MDI) Core
      • National Core: National Diabetes Policy Resource (DPR) Core
    • Enrichment Program
    • Pilot & Feasibility Program
University of Chicago [Website coming by 7/1/2022]
  • Research Aims: The aims of the Chicago Center for Diabetes Translation Research are to increase the impact of rigorous diabetes translation research to reduce disparities in Chicago and the nation by organizing partnerships across academic institutions and stakeholder groups into working groups that include: Clinician-Patient Relationship and Shared Decision Making, Social Determinants of Health, Diabetes Prevention, Diabetes Modeling, Organization and Financing of Care, Diabetes and Aging; and to attract and support diverse investigators who are new to the area of diabetes translation research by providing education, training, mentoring, support for community and stakeholder engagement, pilot and feasibility seed grants, and access to critical translational research core resources. This CDTR combines the complementary strengths of the University of Chicago and Northwestern University, as well as numerous partners and stakeholders, into a city-wide center to amplify the center’s impact on Chicago, the Midwest region, and nation.
  • Activities & Services
    • Cores
      • Research Design, Data, and Analytics Core
      • Community Engagement and Health Equity Core
      • National Core: Accelerating Health Equity and Eliminating Diabetes Disparities in Community Health Centers (AHEAD-CHC)
    • Enrichment Program
    • Pilot & Feasibility Program
University of Colorado
  • Research Aims: The aims of the Center for American Indian and Alaska Native Diabetes Translation Research (CAIANDTR) is to translate research of proven efficacy into practice in both clinical and community settings, with the goal of improving the diabetes-related health of Native people. CAIANDTR builds directly upon our decade-long coordination of the Indian Health Service’s Special Diabetes Program for Indians (SDPI). CAIANDTR provides resources locally, regionally, and nationally in areas relevant to the NIDDK's translation research agenda. Our work is specific to AI/ANs, but is generalizable to other segments of the population. CAIANDTR's specific aims are to: (1) Provide an administrative structure that promotes excellence in translation research and research capacity-building specific to improving diabetes-related health among AI/ANs; (2) Evaluate the impact of training, technical assistance, and consultation activities on the capacity of other investigators to pursue scientifically meritorious diabetes translation research specific to AI/ANs; and (3) Expand training, technical assistance, and consultation activities, delivered through a Research Base of funded faculty, whose research either targets diabetes or is translational in nature with clear potential for application to diabetes.
     
  • Activities & Services
    • Cores
      • Translational Research Core
      • Community Outreach and Engagement Core
      • Health Literacy
      • National Resource Core (NRC)
    • Enrichment Program
    • Pilot & Feasibility Program
      • Research focuses on small scale research projects that explore the extension of diabetes prevention and treatment research – with special emphasis on reducing risk as well as enhancing clinical outcomes – to American Indians and Alaska Natives. There is particular interest in stimulating work that considers the relevance of recent discoveries for application within Native communities.
University of Michigan
  • Research Aims: The goal of the Michigan Center for Diabetes Translational Research (MCDTR) is to advance research along the continuum of diabetes T2-T4 translational research to prevent diabetes and enhance health and wellbeing of people with diabetes, with a specific emphasis on novel approaches to improve health equity. This goal is accomplished by promoting research that supports rapid dissemination, implementation, and sustained use of effective interventions, programs, and policies. The MCDTR fosters and helps sustain multidisciplinary, novel, and cross-sectoral collaborations, including work with multiple health and social service organizations, where appropriate, to advance emerging scientific areas of translational research and health equity.  By attracting, retaining, developing, and supporting early stage and other researchers to conduct research that translates scientific discoveries from bedside to practice and to the community, improvements in diabetes prevention, treatment, population health, and health equity are achievable. 
  • Activities & Services
    • Cores
      • Evaluation Methods and Intervention Strategies Core
      • Addressing Social and Behavioral Determinants of Health Core
      • National Core: Leveraging Community, Peer, and Family Support Core
    • Enrichment Program
    • Pilot & Feasibility Program
Washington University at St. Louis
  • Research Aims: The Washington University Center for Diabetes Translation Research (WU-CDTR) aims to advance a rigorous, scientific evidence base to inform the dissemination, implementation, and sustainability of efficacious interventions for populations at risk for diabetes disparities. The Center is guided by a strategic vision in which a health equity lens is the foundation for transformative diabetes research translated into action and impact. This equity-driven vision informs our Center mission to be the nexus for transdisciplinary team science in advancing the conduct of the next generation of diabetes translation research. The WU-CDTR is a collaboration between Washington University in St. Louis, the Council on Black Health, housed at Drexel University, and the University of Missouri, Columbia.
  • Activities & Services
    • Cores
      • Dissemination and Implementation in Diabetes Research
      • Health Communication and Health Literacy
      • Policy and Systems Science Analysis 
      • Regional Core: Health Informatics in Diabetes Research 
      • National Core: Solutions to Diabetes in Black Americans
    • Enrichment Program
    • Pilot and Feasibility Program

Related Links


Research Resources

NIDDK makes publicly supported resources, data sets, and studies available to researchers to accelerate the rate and lower the cost of new discoveries.

  • Ancillary Studies to Major Ongoing Clinical Studies to extend our knowledge of the diseases being studied by the parent study investigators under a defined protocol or to study diseases and conditions not within the original scope of the parent study but within the mission of the NIDDK.
  • NIDDK Central Repository for access to clinical resources including data and biospecimens from NIDDK-funded studies.
  • NIDDK Information Network (dkNET) for simultaneous search of digital resources, including multiple datasets and biomedical resources relevant to the mission of the NIDDK.

Additional Research Programs

Research Training

Funding Eligibility by Career Level arrow graphic

NIDDK supports the training and career development of medical and graduate students, postdoctoral fellows, and physician scientists through institutional and individual grants.

Learn about NIDDK Research Training Programs

Diversity

Diversity Programs

The NIDDK offers and participates in a variety of opportunities for trainees and researchers from communities underrepresented in the biomedical research enterprise. These opportunities include travel and scholarship awards, research supplements, small clinical grants, high school and undergraduate programs, and a network of minority health research investigators.

Learn about NIDDK Diversity Programs

Small Business

Small Business Programs

NIDDK participates in the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. These programs support innovative research conducted by small businesses that has the potential for commercialization.

Learn about NIDDK Small Business Programs

Human Subjects Research

Human Subjects Research

NIDDK provides funding for pivotal clinical research, from preliminary clinical feasibility to large multi-center studies.

Learn about Human Subjects Research

Translational Research

Translational Research process graphic

NIDDK provides funding opportunities and resources to encourage translation of basic discoveries into novel therapeutics.

Learn about NIDDK Translational Research Opportunities

Meetings & Workshops

  • NIH Common Fund

    Learn about current projects and view funding opportunities sponsored by the NIH Common Fund.

  • Planning to Apply? Register Early

    Registration is required at eRA Commons and grants.gov and can take 4 weeks.